GNH USA

Europe — EMA

Nuvaring (Ethinylestradiol, Etonogestrel)

GNH USA supplies Nuvaring (Ethinylestradiol, Etonogestrel), a combined hormonal contraceptive for pregnancy prevention. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Ethinylestradiol, Etonogestrel?

Ethinylestradiol and etonogestrel, the active ingredients in Nuvaring, are synthetic hormones presented as a vaginal contraceptive ring for vaginal use. They work together to prevent pregnancy in women of reproductive age. GNH USA supplies Nuvaring as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ethinylestradiol, Etonogestrel used for?

Nuvaring is a combined hormonal contraceptive that acts on the hypothalamic‑pituitary‑ovarian axis to prevent pregnancy. - Contraception: provides reliable, reversible birth control by suppressing ovulation and thickening cervical mucus. - Menstrual cycle regulation: helps achieve more predictable monthly bleeding patterns. - Reduction of menstrual discomfort: can lessen dysmenorrhea and heavy bleeding associated with the menstrual cycle.

What are the side effects of Ethinylestradiol, Etonogestrel?

Common Side Effects: - Vaginal irritation or discharge: mild irritation at the insertion site. - Headache: transient tension‑type headaches. - Nausea: occasional mild stomach upset. - Breast tenderness: temporary swelling or soreness. - Mood changes: irritability or mild mood swings. - Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects: - Venous thromboembolism: deep vein thrombosis or pulmonary embolism. - Stroke or myocardial infarction: rare but life‑threatening events. - Liver tumor: hepatic adenoma or carcinoma. - Severe allergic reaction: anaphylaxis, rash, or swelling. - Gallbladder disease: cholelithiasis or cholecystitis. - Hyperglycemia: elevated blood sugar in susceptible individuals.

What precautions apply to Ethinylestradiol, Etonogestrel?

Before using Nuvaring, consider the following precautions: - Smoking: avoid use if over 35 and a smoker due to increased clot risk. - Cardiovascular disease: contraindicated in women with history of heart attack, stroke, or uncontrolled hypertension. - Liver disorders: use with caution in hepatic impairment. - Cancer history: avoid if personal or family history of estrogen‑dependent tumors. - Medication review: discuss all current drugs with a healthcare professional. - Store at room temperature: keep in original packaging, protect from moisture and excessive heat.

What does Ethinylestradiol, Etonogestrel interact with?

Nuvaring may interact with several medicines, altering its effectiveness or safety. Major Interactions (Avoid): - Rifampin, phenytoin, carbamazepine, St. John’s wort: strong CYP3A4 inducers that reduce contraceptive efficacy. - Other estrogen‑containing products: increase risk of thromboembolic events. - Certain antiretrovirals (e.g., efavirenz): may lower hormone levels.

Moderate Interactions (Monitor Closely): - Antifungals such as ketoconazole: may increase hormone concentrations. - Antibiotics (e.g., tetracycline, metronidazole): slight reduction in effectiveness, monitor for breakthrough bleeding. - SSRIs and SNRIs: potential for increased mood‑related side effects. - Herbal supplements (e.g., ginseng): may affect hormone metabolism.

Frequently asked questions

What is Nuvaring used for?+
Nuvaring is a combined hormonal contraceptive vaginal ring that provides reversible birth control for women of reproductive age. It prevents pregnancy by suppressing ovulation, thickening cervical mucus, and stabilizing the uterine lining, offering a convenient, month‑long dosing schedule.
How does ethinylestradiol work in Nuvaring?+
Ethinylestradiol, a synthetic estrogen, binds to estrogen receptors and helps regulate the menstrual cycle. In Nuvaring, it works together with etonogestrel to inhibit the luteinizing hormone surge, preventing ovulation and contributing to the contraceptive effect.
What is the usual dose of Nuvaring?+
The dosing regimen for Nuvaring is determined by the prescribing healthcare professional. Typically, a single ring is inserted vaginally and left in place for three weeks, followed by a one‑week ring‑free interval, but the exact schedule should follow the prescriber's instructions.
Is Nuvaring safe to use during pregnancy or breastfeeding?+
Nuvaring is intended for use only when a woman is not pregnant. If pregnancy occurs, the ring should be removed immediately. It is not recommended for breastfeeding mothers, as hormonal exposure may affect milk production and infant exposure.
How do I order Nuvaring from GNH USA?+
To order Nuvaring, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does Nuvaring compare with other combined hormonal contraceptives?+
Nuvaring offers a month‑long vaginal delivery system, eliminating daily oral dosing required by pills. This can improve adherence and provide more stable hormone levels. Compared with transdermal patches or injectables, the ring is non‑invasive, easily removable, and does not require injections or skin patches.
What are the storage and handling requirements for Nuvaring?+
Nuvaring should be stored at room temperature, below 25 °C, in its original packaging. Protect the ring from moisture, direct sunlight, and extreme heat to maintain its integrity and efficacy throughout the shelf life.
How is Nuvaring administered?+
Nuvaring is a flexible vaginal ring that is inserted into the upper vagina by the user or a healthcare professional. It remains in place for three weeks, after which it is removed for a one‑week ring‑free interval before a new ring is inserted.
What are the most serious risks associated with Nuvaring?+
Serious risks include venous thromboembolism, stroke, myocardial infarction, and rare liver tumors. Women with a history of clotting disorders, cardiovascular disease, smoking over age 35, or certain cancers should avoid using Nuvaring.
Who should not use Nuvaring?+
Nuvaring is contraindicated in women who are pregnant, have a known or suspected estrogen‑dependent tumor, have active liver disease, have uncontrolled hypertension, have a history of thromboembolic events, or are smokers over 35 years old.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ethinylestradiol, Etonogestrel
Route
Vaginal Use
Manufacturer
Organon Biosciences S.R.L.
Origin
EU

Related products